kabutan

D.Western Therapeutics Institute, First Half Net Income Loss Narrows, Apr-Jun Net Income Loss Narrows

Thu Aug 14, 2025 3:30 pm JST Earnings

4576 D.Western Therapeutics Institute, Inc. 【J-GAAP】

Earnings Report

D.Western Therapeutics Institute, Inc. <4576> [TSE Growth] announced its financial results after the market closed on August 14th (15:30). The consolidated net loss for the cumulative second quarter of the fiscal year ending December 2025 (January to June) was a reduced loss of 316 million yen (compared to a loss of 520 million yen in the same period last year).

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net loss for the July to December period (second half) is expected to further decrease loss of 364 million yen (compared to a loss of 770 million yen in the same period last year).

In the most recent three-month period, from April to June (2Q), the consolidated net loss improved to a deficit of 166 million yen (compared to a loss of 200 million yen in the same period last year). However, the operating profit/loss margin drastically worsened from -110.1% in the same period last year to -216.9%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Jun, 2023 187 -258 -254 -247 -7.9 ー Aug 10, 2023 J-GAAP
Jan - Jun, 2024 223 -449 -459 -520 -16.2 ー Aug 9, 2024 J-GAAP
Jan - Jun, 2025 173 -309 -316 -316 -7.1 ー Aug 14, 2025 J-GAAP
YoY -22.4% +31.2% +31.2% +39.2% +56.2%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 Guidance ー ー ー ー － 0 Feb 10, 2025 J-GAAP
Jan - Jun, 2025 Results 173 -309 -316 -316 -7.1 0 Aug 14, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 248 -760 -769 -770 -21.9 0 Feb 10, 2025 J-GAAP
Jul - Dec, 2025 Guidance 227 -361 -364 -364 -6.7 0 Aug 14, 2025 J-GAAP
YoY -8.5% +52.5% +52.7% +52.7% +69.4%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 428 -798 -796 -812 -25.6 0 Feb 9, 2024 J-GAAP
Dec, 2024 471 -1,209 -1,228 -1,290 -36.7 0 Feb 10, 2025 J-GAAP
Dec, 2025 Guidance 400 -670 -680 -680 -12.6 0 Feb 10, 2025 J-GAAP
YoY -15.1% +44.6% +44.6% +47.3% +65.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 119 -131 -139 -200 -6.2 -110.1 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 125 -198 -206 -207 -6.2 -158.4 Nov 14, 2024 J-GAAP
Oct - Dec, 2024 123 -562 -563 -563 -16.0 -456.9 Feb 10, 2025 J-GAAP
Jan - Mar, 2025 96 -142 -149 -150 -3.4 -147.9 May 15, 2025 J-GAAP
Apr - Jun, 2025 77 -167 -167 -166 -3.7 -216.9 Aug 14, 2025 J-GAAP
YoY -35.3% -27.5% -20.1% +17.0% +40.1%

Related Articles